UPGRADE-Studie: Neuer Herzinfarktmarker GPBB soll Untersuchungen beschleunigen
Mit der UPGRADE-Studie (Unified Protocol for GPBB Rapid ACS Diagnosis Enhancement) startet Diagenics International Corpo…
Mit der UPGRADE-Studie (Unified Protocol for GPBB Rapid ACS Diagnosis Enhancement) startet Diagenics International Corpo…
SIRION BIOTECH und Heidelberger TET Systems schließen Lizenzvereinbarung München/Martinsried, TET Systems (TET) un…
Das Berliner Biotech-Unternehmen MOLOGEN hat heute mit seinem Krebsmedikament MGN1703 die klinische Phase 2 Studie begon…
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) is pleased to announce that imaGenes GmbH, located in Berlin, Germany, has…
A shift in the life science market has begun to steer cell culture scientists to reevaluate their use of native transfer…
InVitria is attending the 9th Annual Biological Production Forum in Frankfurt, Germany June 21st through the 23rd. This…
STRATEC Biomedical Systems AG, Birkenfeld, Deutschland, (Frankfurt: SBS; Prime Standard) und bioMérieux (NYSE Euronext:…
Der Dresdner Wissenschaftler Professor Dr. med Kai Simons, Direktor Emeritus des Max-Planck-Institutes für Genetik und Z…
InVitria announced the launch of ITSE Animal-Free(TM) , a recombinant and defined cell culture media supplement that pro…